Avista Sells Accuratus Facility

Avista Pharma Solutions, Inc. sold its facility in Eagan, MN to Microbiology Research Associates, a portfolio company of Thompson Street Capital Partners. The Eagan facility, which operates as Accuratus Lab Services (Accuratus), provides testing services for antimicrobial products that are regulated by the Environmental Protection Agency (EPA). The sale is a strategic exit for Ampersand Capital Partners, the private equity owner of Avista Pharma, and allows Avista Pharma to focus on its core market in pharmaceutical contract services.
 
“Our Accuratus site in Eagan has been a high-performing site for Avista Pharma, and we want to thank the leadership team and employees for their dedication to the business,” said Mr. Patrick Walsh, chief executive officer of Avista Pharma.
 
Avista Pharma was formed through the strategic combination of three businesses serving the pharmaceutical, animal health and medical device industries. Avista Pharma is a contract testing, development and manufacturing organization with locations in Durham, NC; Longmont, CO and Agawam, MA.
 
Avista Pharma was represented by investment banking firm Fairmount Partners based in West Conshohocken, PA.